The Cyprus Institute of Neurology and Genetics announces its inclusion as a new partner in the European project PoCCardio (Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients), which aims to improve the prediction and prevention of myocardial infarctions.
As part of the project, 1,800 patients with a history of heart attack are participating in clinical trials, where important medical data and biomarker measurements are collected to aid in the diagnosis and prognosis of diseases.
The project is funded by the European Union through Horizon Europe with a budget of €14 million. For its contribution to the implementation of the project, CINK secured funding of €540,000.
The Bioinformatics Department of CINK, specialising in Computational Diagnostics and Therapeutics, headed by Dr. Anastasis Oula, Associate Scientist, will use modern methods that analyse biological data as a large information network.
Network creation and risk prediction
Within the framework of PoCCardio, the Bioinformatics Department of INK will use network creation tools to reveal functional and clinically significant interactions between biomarkers, creating a network based on the project’s genomic and proteomic biomarkers, as well as available public data on proteins and genetic polymorphisms associated with cardiovascular disease. From these networks, algorithms will be trained to reliably predict the risk of myocardial infarction.
In addition, based on the enriched biomarker measurements, the Bioinformatics Department of INK will develop a diagnostic protocol for predicting the risk of infarction that will utilise data from the PoCCardio point-of-care device device, enabling fast and effective analysis through advanced artificial intelligence, thus supporting the project’s goal of timely and cost-effective determination of patient risk profiles.
CING is participating in the project as a ‘Hop-on Facility’ under the Horizon Europe programme ‘Widening participation and spreading excellence’, which enables research organisations from enlargement countries to participate in Horizon Europe projects.
Source: Cyprus Institute of Neurology & Genetics | News & Events | Media (https://tinyurl.com/yc55uhwv)